Roche

Roche aims for 11 late-stage trials in cancer immunotherapy drug this year
Yahoo/Reuters
Mon, 04/13/15 - 06:05 pm
Roche
cancer immunotherapy
Roche snags a genomics startup with an eye on cancer R&D
Fierce Biotech
Mon, 04/13/15 - 05:46 pm
Roche
genomics
R&D
CAPP Medical
Roche’s Arthritis Blockbuster Holds Promise for Diabetes
Bloomberg
Fri, 04/10/15 - 10:46 am
Roche
type 1 diabetes
Actemra
Rituxan may have rare-disease use
Medical Marketing and Media
Tue, 04/7/15 - 09:55 am
Rituxan
Roche
EGPA
Did Novartis try to sabotage Avastin ophthalmic trials?
BioPharma Dive
Mon, 04/6/15 - 10:54 am
Novartis
Avastin
Roche
Lucentis
BMJ: Novartis tried to 'scupper' trials to protect Lucentis from cheap Avastin
Fierce Pharma
Thu, 04/2/15 - 11:52 am
Novartis
clinical trials
Roche
Avastin
Lucentis
Roche open to alliances in hunt for cancer drug combinations
Yahoo/Reuters
Wed, 04/1/15 - 08:39 am
Roche
immuno-oncology
Genentech project to add 100 jobs
Fierce Pharma
Fri, 03/27/15 - 10:24 am
Genentech
Roche
drug manufacturing
Prothena rockets up with early data on a Roche-partnered Parkinson's drug
Fierce Biotech
Fri, 03/20/15 - 08:24 am
Roche
Prothena
PRX002
Parkinson's Disease
Top 15 pharma companies by 2014 revenue
Fierce Pharma
Wed, 03/18/15 - 11:04 am
JNJ
Novartis
Roche
Pfizer
Sanofi
Merck
GSK
AstraZeneca
Bayer
Amgen, Inc. Plans For Biosimilar Launches
Bidness Etc.
Tue, 03/10/15 - 08:21 am
Amgen
biosimilars
Roche
AbbVie
Neupogen
Expect More M&A Activity In Red-Hot Biotech Group
Investors.com
Fri, 03/6/15 - 03:09 pm
biotech
M&A
AbbVie
Pharmacyclics
Isis Pharmaceuticals
JNJ
Merck
NewLink Genetics
Roche
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
UK
Avastin
off-label
Lucentis
wet age-related macular degeneration
Roche
Novartis
Residents want to sue Roche before it gives up New Jersey campus
Fierce Pharma
Thu, 02/19/15 - 01:53 pm
Roche
New Jersey
Roche and Exelixis roll toward FDA approval with a melanoma cocktail
Fierce Biotech
Thu, 02/19/15 - 10:41 am
Roche
Exelixis
FDA
melanoma
Cobimetinib
Zelboraf
BRAF inhibitor
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Pfizer
immuno-oncology
AstraZeneca
Bristol-Myers Squibb
Merck
Roche
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Supplies of Roche's Tamiflu drained in HK as monthlong H3N2 outbreak hits
Fierce Pharma
Thu, 02/12/15 - 10:08 am
Roche
Tamiflu
influenza
Hong Kong
H3N2
Pharma Files Complaint Against Italy for Reimbursing Off-Label Prescribing
WSJ Pharmalot
Tue, 02/10/15 - 06:40 pm
Italy
off-label
Avastin
Lucentis
Roche
Novartis

Pages